ロード中...
Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
BACKGROUND: Biological disease-modifying antirheumatic drugs (bDMARDs) are recommended for rheumatoid arthritis (RA), but older patients reportedly experience more adverse events (AEs) and show variable treatment response. The objective of this study was to evaluate AEs and effectiveness of bDMARDs...
保存先:
| 出版年: | Can Geriatr J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Canadian Geriatrics Society
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7259924/ https://ncbi.nlm.nih.gov/pubmed/32494334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5770/cgj.23.393 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|